FDA approves first spironolactone oral suspension
August 9, 2017
After more than 50 years on the U.S. market, spironolactone is available in liquid form, bypassing the compounding pharmacist.
Opioid prescribing drops nationally, remains high in some counties
July 7, 2017
The CDC calls for “more consistency among health care providers” when it comes to prescribing opioids.
FDA approves betrixaban for VTE prophylaxis
June 23, 2017
An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.